I am glad to report that we have been admitted to the NIH Commercialization Acceleration Program or NIH CAP. Through this program NIH enhances commercialization opportunities for selected companies that have received SBIR Phase II funding. The program is run in collaboration with the Larta Institute in Los Angeles, and a mentor from the institute is paired with each company. In the time span of 9 months Larta helps companies develop an effective commercialization plan. To date the NIH CAP program assisted more than 1K companies and resulted in more than $1B of non-government investment in the assisted companies.
NES as been admitted to the Commercialization Transition Track, where we will be developing an optimal commercialization strategy for Accubalte™, our first product as a company.
Above: landing page of the NIH CAP – https://sbir.nih.gov/cap